Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction, and Cooley represented Candid Therapeutics. Candid Therapeutics, a biotechnology company, acquired Vignette Bio...
Vignette Bio’s Merger with Candid Therapeutics
Structure Therapeutics’ $185.3 Million IPO
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Drata’s $100 Million Series B Financing Round
Cooley LLP advised Drata on the deal. Drata, a next-generation security and compliance automation company, announced its $100 million Series B financing round, which brings the company’s...
Grupo Halcón’s Acquisition of Industrial Assets of Cicogres
Cuatrecasas represented Grupo Halcón in the transaction. Grupo Halcón executed the acquisition—through insolvency proceedings— of the industrial assets of Cicogres, a Castellón-based ceramic tile producer, with...
The Honest Company’s $475 Million IPO
Cooley LLP advised The Honest Company on the deal. The Honest Company, a consumer goods company founded by actress Jessica Alba, announced its $475 million initial public...